OTTESEN; Lone
Patent Applications and Registrations
Patent applications and USPTO patent grants for OTTESEN; Lone.The latest application filed is for "ezh2 inhibitors for treating lymphoma".
- OTTESEN; Lone - London GB
- Ottesen; Lone - Stockley Park GB
- Ottesen; Lone - Uxbridge GB
| Patent | Date |
|---|---|
| Ezh2 Inhibitors For Treating Lymphoma App 20200323866 - KEILHACK; Heike ; et al. | 2020-10-15 |
| Ezh2 Inhibitors For Treating Lymphoma App 20200022987 - KEILHACK; Heike ; et al. | 2020-01-23 |
| Ezh2 Inhibitors For Treating Lymphoma App 20190175604 - KEILHACK; Heike ; et al. | 2019-06-13 |
| EZH2 inhibitors for treating lymphoma Grant 10,166,238 - Keilhack , et al. J | 2019-01-01 |
| Methods Of Treating Cancer App 20180280470 - Hambleton; Julie ; et al. | 2018-10-04 |
| Ezh2 Inhibitors For Treating Lymphoma App 20170216300 - KEILHACK; Heike ; et al. | 2017-08-03 |
| Methods Of Treating Cancer App 20160067307 - Hambleton; Julie ; et al. | 2016-03-10 |
| Methods Of Treating Cancer App 20130252956 - Kallender; Howard ; et al. | 2013-09-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 